ArticleFrontiers in pharmacology2025

A cost-effectiveness analysis of baloxavir marboxil versus oseltamivir for seasonal influenza treatment in China.

Fangyu Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.